Home/DAMONA Pharmaceuticals/John Reilly

JR

John Reilly

Chief Executive Officer

DAMONA Pharmaceuticals

Roles

Chief Executive OfficeratDAMONA Pharmaceuticals

Chief Operating OfficeratTalkspace

Therapeutic Areas

Neurodegenerative diseases Psychiatric disorders Cognitive impairment

DAMONA Pharmaceuticals Pipeline

Drug	Indication	Phase
DPX-101	Cognitive deficits in Alzheimer’s disease and other CNS disorders	Phase 1

Leadership Team at DAMONA Pharmaceuticals

Etienne Sibille, PhD

Scientific Founder

Rob Risinger, MD

Consulting Chief Medical Officer

View full DAMONA Pharmaceuticals profile